Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention

被引:0
|
作者
H.-J. Cho
I.-H. Chae
K.-W. Park
J.-R. Ju
S. Oh
M.-M. Lee
Y.-B. Park
机构
[1] Heart Research Institute,
[2] Medical Research Center,undefined
[3] Seoul National University,undefined
[4] Seoul,undefined
[5] Korea,undefined
[6] Department of Internal Medicine,undefined
[7] Seoul National University College of Medicine,undefined
[8] 28 Yongon-dong Chongno-gu,undefined
[9] Seoul 110-744,undefined
[10] Korea Tel. +82-2-760-2684; Fax +82-2-766-8944 e-mail: ihchae@snu.ac.kr,undefined
[11] Cardiovascular Research Laboratory,undefined
[12] Clinical Research Institute,undefined
[13] Seoul National University Hospital,undefined
[14] Seoul,undefined
[15] Korea,undefined
来源
Journal of Human Genetics | 2002年 / 47卷
关键词
Key words Gelatinase B; Polymorphism; Matrix metalloproteinase; Coronary artery disease; Atherosclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
The matrix metalloproteinases appear to play an important role in the development and progression of atherosclerotic lesions. We studied the C-1562T polymorphism of the gelatinase B promoter in relation to coronary artery disease and restenosis after a percutaneous coronary intervention (PCI) in Koreans. To determine the frequency of the C-1562T allele, we examined 63 patients with coronary artery disease who underwent both PCI and 6-month follow-up coronary angiograms (CAGs), and 67 control patients with a normal CAG with respect to their clinical data and genotype. Frequencies of the C/C homozygotes and the non-C/C heterozygotes and homozygotes (C/T and T/T) were 94% and 6% in the normal CAG group, and 76.2% and 23.8% in the patient group, respectively. This gave a relative risk of 0.203 (95% CI: 0.063–0.651, P = 0.005) for coronary artery disease when the C/C genotype was compared with the non-C/C genotype. In the patient groups, the allele frequencies of the C/C and non-C/C were 80% and 20% in the nonrestenotic subgroup, and 71.4% and 28.6% in the restenotic subgroup (P = 0.554). No T/T homozygote was found in any of the groups. We conclude that C/C homozygosity is a potential genetic protective factor for coronary artery disease in Koreans.
引用
收藏
页码:88 / 91
页数:3
相关论文
共 50 条
  • [1] Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention
    Cho, HJ
    Chae, IH
    Park, KW
    Ju, JR
    Oh, S
    Lee, MM
    Park, YB
    JOURNAL OF HUMAN GENETICS, 2002, 47 (02) : 88 - 91
  • [2] RANTES gene promoter polymorphisms and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention
    Vogiatzi, K.
    Voudris, V.
    Apostolakis, S.
    Kochiadakis, G. E.
    Thomopoulou, S.
    Zaravinos, A.
    Arfanakis, D. A.
    Spandidos, D. A.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2009, 30 : 103 - 103
  • [3] Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention
    Vogiatzi, Konstantina
    Voudris, Vassilis
    Apostolakis, Stavros
    Kochiadakis, Georgios E.
    Thomopoulou, Sofia
    Zaravinos, Apostolos
    Spandidos, Demetrios A.
    THROMBOSIS RESEARCH, 2009, 124 (01) : 84 - 89
  • [4] Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis
    Zhang, BP
    Ye, S
    Herrmann, SM
    Eriksson, P
    de Maat, M
    Evans, A
    Arveiler, D
    Luc, G
    Cambien, F
    Hamsten, A
    Watkins, H
    Henney, AM
    CIRCULATION, 1999, 99 (14) : 1788 - 1794
  • [5] Interleukin 1 receptor antagonist gene polymorphism and restenosis after percutaneous coronary intervention
    Erglis, A
    Kainins, U
    Licis, N
    Narbute, I
    Jegere, S
    Latkovskis, G
    Stradins, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 46A - 46A
  • [6] The Tumor Suppressor Gene Polymorphism is Associated with Risk of Restenosis after Percutaneous Coronary Intervention
    Zhong, Chen
    Qi, Qian
    Ma, Genshan
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 94I - 94I
  • [7] Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention
    Prskalo, Zrinko
    Brizic, Ivica
    Markota, Darko
    Markota, Ivica
    Boban, Mladen
    Tomic, Monika
    Starcevic, Boris
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [8] Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention
    Zrinko Prskalo
    Ivica Brizić
    Darko Markota
    Ivica Markota
    Mladen Boban
    Monika Tomic
    Boris Starcevic
    BMC Cardiovascular Disorders, 16
  • [9] Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
    Zheng, Guo Hua
    Liu, Jian Ping
    Chu, Jian Feng
    Mei, Lijuan
    Chen, Hai Ying
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [10] CCL5 and CXCL8 gene polymorphisms and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention
    Apostolakis, S.
    Vogiatzi, K.
    Voudris, K.
    Zaravinos, A.
    Thomopoulou, S.
    Kochiadakis, G. E.
    Spandidos, D. A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S12 - S12